Geriatric Medicine in San Francisco, CA
5 verified geriatric medicine doctors in San Francisco.
Geriatricians provide comprehensive primary and specialty care tailored to older adults.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Jennifer Morris, MD
Geriatric Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Theresa Allison, MD
Geriatric Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Paul Abramson, MD
Geriatric Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Rong Shen, MD
Geriatric Medicine
CMS Open Payments· $316.27 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$316.27
Total received
4
Transactions
3
Paying companies
Top paying companies
Among the 1,695 geriatric medicine doctors we've analyzed, about 29% received any industry payment (median $122 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US geriatric medicine doctors.
Payments to Rong Shen do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Richard Zercher, MD
Geriatric Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.